https://biotechmorning.com/news/400m-bet-fixing-blindness-big-pharma-walked-away Biotech Morning en 2026-07-10T14:26:57.323Z The $400M Bet on Fixing Blindness That Big Pharma Walked Away From https://biotechmorning.com/news/roche-kills-two-huntingtons-programs Biotech Morning en 2026-07-10T14:26:00.889Z Roche Just Killed Its Huntington's Drug RG6496 — And Tominersen Results Offer No Hope Either https://biotechmorning.com/news/trump-100-percent-tariff-brand-name-drugs Biotech Morning en 2026-07-10T14:25:07.088Z The $0 Pill Just Got a 100% Price Tag at the Border https://biotechmorning.com/news/chikungunya-vaccine-ixchiq-pulled-us-market Biotech Morning en 2026-07-10T14:24:11.625Z The Only Chikungunya Vaccine Just Got Pulled. Now What? https://biotechmorning.com/news/car-t-systemic-sclerosis-fate-therapeutics Biotech Morning en 2026-07-10T14:23:20.978Z Cancer's Most Famous Weapon Just Showed Up in a Disease Nobody Expected https://biotechmorning.com/news/moderna-h5-bird-flu-vaccine-phase-3-trial Biotech Morning en 2026-07-10T14:22:28.690Z Moderna's Bet on the Next Pandemic Just Entered the Final Round https://biotechmorning.com/news/moderna-combined-flu-covid-vaccine-eu-approval Biotech Morning en 2026-07-10T14:21:36.161Z One Shot to Rule Them All: The Vaccine That Replaces Two https://biotechmorning.com/news/bms-krazati-chemo-colorectal-cancer-failure Biotech Morning en 2026-07-10T14:20:44.169Z BMS Built a Smarter Cancer Drug. Chemo Still Won. https://biotechmorning.com/news/keytruda-biosimilar-samsung-bioepis-sb27-phase-3 Biotech Morning en 2026-07-10T14:19:49.604Z The Best-Selling Drug Just Met Its Copycat https://biotechmorning.com/news/china-glp1-essential-medicines-semaglutide Biotech Morning en 2026-07-10T14:18:59.727Z Beijing's GLP-1 Power Play Could Reshape the World's Biggest Diabetes Market https://biotechmorning.com/news/satellos-muscle-remodeling-adult-duchenne Biotech Morning en 2026-07-09T14:26:15.884Z The Muscle Disease That Only Gets Worse Just Got Better https://biotechmorning.com/news/trump-tax-bill-biotech-giveth-taketh Biotech Morning en 2026-07-09T14:25:24.329Z The Tax Bill That Giveth and Taketh Away From Biotech https://biotechmorning.com/news/astrazeneca-sino-biopharma-copd-deal Biotech Morning en 2026-07-09T14:24:31.243Z AstraZeneca Just Paid $200M to Pick a Fight with Merck Over Your Lungs https://biotechmorning.com/news/sino-biopharm-lanova-acquisition-bispecific-antibody Biotech Morning en 2026-07-09T14:23:38.295Z The $500 Million Shortcut That Bought a Billion-Dollar Biotech https://biotechmorning.com/news/ebola-jumps-new-province-no-weapons Biotech Morning en 2026-07-09T14:22:44.274Z Ebola Just Jumped to a New Province. Nobody Has the Right Weapons. https://biotechmorning.com/news/fda-commissioner-search-2026-white-house-contenders Biotech Morning en 2026-07-09T14:21:47.911Z The FDA Needs a New Boss. Nobody Knows Who It'll Be. https://biotechmorning.com/news/tavneos-nejm-retraction-advocate-trial Biotech Morning en 2026-07-09T14:20:56.487Z The Billion-Dollar Drug Built on a Paper That No Longer Exists https://biotechmorning.com/news/gsk-alector-700-million-alzheimers-deal-dead Biotech Morning en 2026-07-09T14:20:06.870Z GSK Just Lit $700 Million on Fire (and Walked Away) https://biotechmorning.com/news/prime-medicine-beam-patent-ruling-gene-editing Biotech Morning en 2026-07-09T14:19:10.260Z The Gene-Editing Turf War That Could Redraw the Entire CRISPR Map